Blood loss in surgical oncology: Neglected quality indicator?

Journal of Surgical Oncology

Volumn 99, Issue 8, 2009, Pages 508-512

  Dixon, Elijah ^a,c   Datta, Indraneel ^a   Sutherland, Francis R ^a   Vauthey, Jean Nicolas ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bloodloss; Quality indicator; Surgical oncology

Indexed keywords

ACUTE LUNG INJURY; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; HEALTH CARE QUALITY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; KIDNEY CARCINOMA; LENGTH OF STAY; LIVER CANCER; LIVER RESECTION; LUNG CANCER; MORTALITY; ONCOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCREENING TEST; SEROCONVERSION; STOMACH CANCER; SURGICAL PATIENT; TREATMENT OUTCOME; VIRUS TRANSMISSION; NEOPLASM; STATISTICS; SURVIVAL; TUMOR RECURRENCE;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; QUALITY INDICATORS, HEALTH CARE; SURVIVAL ANALYSIS;

EID: 67049164906     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21187     Document Type: Review

References (43)

1. Gagliardi AR, Fung MF, Langer B, et al.: Development of ovarian cancer surgery quality indicators using a modified Delphi approach. Gynecol Oncol 2005;97:446-456. (Pubitemid 40614889)
2. Donabedian A: The quality of care. How can it be assessed? Jama 1988;260:1743-1748.
3. Marshall M, Campbell C, Hacker J, et al.: Quality indicators for general practice. London: Royal Society of Medicine; 2002.
4. McGory ML, Shekelle PG, Ko CY: Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst 2006;98:1623-1633. (Pubitemid 44811645)
5. Gagliardi AR, Fleshner N, Langer B, et al.: Development of prostate cancer quality indicators: a modified Delphi approach. Can J Urol 2005;12:2808-2815.
6. Gagliardi AR, Simunovic M, Langer B, et al.: Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach. Can J Surg 2005;48:441-452. (Pubitemid 43117094)
7. Malin JL, Asch SM, Kerr EA, et al.: Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool. Cancer 2000;88:701-707. (Pubitemid 30056948)
8. Porter GA, Skibber JM: Outcomes research in surgical oncology. Ann Surg Oncol 2000;7:367-375. (Pubitemid 30397479)
9. Helyer LK, O'Brien C, Coburn NG, et al.: Surgeons' knowledge of quality indicators for gastric cancer surgery. Gastric Cancer 2007;10:205-214. (Pubitemid 350308168)
10. Goodnough LT, Shander A, Spence R: Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003;43:668-676. (Pubitemid 36506366)
11. Hebert PC, Wells G, Blajchman MA, et al.: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-417.
12. Goodnough LT: Risks of blood transfusion. Crit Care Med 2003;31:S678-686.
13. Baskett TF: James Blundell: the first transfusion of human blood. Resuscitation 2002;52:229-233.
14. Opelz G, Terasaki PI: Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978;299:799-803. (Pubitemid 9044523)
15. Salvatierra O Jr, Vincenti F, Amend W, et al.: Deliberate donor-specific blood transfusions prior to living related renal transplantation. A. new approach. Ann Surg 1980;192:543-552. (Pubitemid 11225438)
16. Glass NR, Miller DT, Sollinger HW, et al.: A four-year experience with donor blood transfusion protocols for living-donor renal transplantation. Transplantation 1985;39:615-619. (Pubitemid 15066951)
17. Williams KA, Ting A, French ME, et al.: Peroperative blood-transfusion improve cadaveric renal-allograft survival in nontransfused recipients. A. prospective controlled clinical trial. Lancet 1980;1:1104-1106.
18. Agarwal N, Murphy JG, Cayten CG, et al.: Blood transfusion increases the risk of infection after trauma. Arch Surg 1993;128:171-176 discussion 176-177. (Pubitemid 23057641)
19. Hill GE, Frawley WH, Griffith KE, et al.: Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003;54:908-914. (Pubitemid 36758801)
20. Nielsen HJ: Detrimental effects of perioperative blood transfusion. Br J Surg 1995;82:582-587.
21. Jensen LS, Hokland M, Nielsen HJ: A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996;83:973-977. (Pubitemid 26228219)
22. Borleffs JC, Marquet RL, de By-Aghai Z, et al.: Kidney transplantation in rhesus monkeys. Matching for D/DR antigens, pretransplant blood transfusions, and immunological monitoring before transplantation. Transplantation 1982;33:285-290.
23. Jensen LS, Andersen AJ, Christiansen PM, et al.: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-516.
24. Busch OR, Hop WC, Marquet RL, et al.: Prognostic impact of blood transfusions on disease-free survival in colorectal carcinoma. Scand J Gastroenterol Suppl 1993; 20021-20023. (Pubitemid 24093219)
25. Stephan RN, Kupper TS, Geha AS, et al.: Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987;122:62-68. (Pubitemid 17229259)
26. McAlister FA, Clark HD, Wells PS, et al.: Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 1998;85:171-178. (Pubitemid 28099931)
27. Busch OR, Hop WC, Marquet RL, et al.: Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 1994;220:791-797.
28. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al.: Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-1376. (Pubitemid 23131389)
29. Skanberg J, Lundholm K, Haglind E: Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancer. Acta Oncol 2007;46:1123-1130. (Pubitemid 350058886)
30. van de Watering LM, Brand A, Houbiers JG, et al.: Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 2001;88:267-272. (Pubitemid 32142717)
31. Miki C, Hiro J, Ojima E, et al.: Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol) 2006;18:60-66. (Pubitemid 43056698)
32. Crowe JP, Gordon NH, Fry DE, et al.: Breast cancer survival and perioperative blood transfusion. Surgery 1989;106:836-841. (Pubitemid 19283376)
33. Kooby DA, Stockman J, Ben-Porat L, et al.: Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860-869. discussion 869-870. (Pubitemid 38174522)
34. Chen G, Zhang FJ, Gong M, et al.: Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. J Zhejiang Univ Sci B 2007;8: 560-565.
35. Fong Y, Karpeh M, Mayer K, et al.: Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-260. (Pubitemid 24260251)
36. Hyman NH, Foster RS Jr, DeMeules JE, et al.: Blood transfusions and survival after lung cancer resection. Am J Surg 1985;149: 502-507. (Pubitemid 15050911)
37. Little AG, Wu HS, Ferguson MK, et al.: Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990;160:630-632. discussion 633.
38. Manyonda IT, Shaw DE, Foulkes A, et al.: Renal cell carcinoma: blood transfusion and survival. Br Med J (Clin Res Ed) 1986; 293:537-538. (Pubitemid 16051195)
39. Moores DW, Piantadosi S, McKneally MF: Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg 1989;47:346-351. (Pubitemid 19100462)
40. Sutherland F, Mackenzie S, Bathe O, et al.: Measuring blood loss during hepatectomy. HPB (in press).
41. Gross JB: Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983;58:277-280.
42. Gohel MS, Bulbulia RA, Slim FJ, et al.: How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Ann R Coll Surg Engl 2005; 87:3-14. (Pubitemid 40104225)
43. Fujita S, Kim ID, Uryuhara K, et al.: Hepatic grafts from live donors: donor morbidity for 470 cases of live donation. Transpl Int 2000;13:333-339. (Pubitemid 30757149)